Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ashby

Showing results (41-50 of 215) with videos related to

Pageof 22
Sort By:
The Cochrane Database of Systematic Reviews|May 5, 2000
Ursodeoxycholic acid for cystic fibrosis-related liver diseaseK Cheng, D Ashby, R Smyth
The Cochrane Database of Systematic Reviews|May 5, 2000
Oral steroids for cystic fibrosisK Cheng, D Ashby, R Smyth
Journal of the Royal Society of Medicine|January 1, 1997
Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic reviewK Cheng, D Ashby, R Smyth
The Journal of Biological Chemistry|February 25, 1973
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzymeC D Ashby, D A Walsh
Lifetime Data Analysis|January 1, 1996
A Bayesian approach to Weibull survival models--application to a cancer clinical trialK Abrams, D Ashby, D Errington
Journal of the American Chemical Society|May 5, 2005
Ultra-sensitive imaging and interfacial analysis of patterned hydrophilic SAM surfaces using energy dissipation chemical force microscopyPaul D Ashby, Charles M Lieber
Recent Progress in Hormone Research|January 1, 1973
Protein kinases: aspects of their regulation and diversityD A Walsh, C D Ashby
Controlled Clinical Trials|October 1, 1994
Simple Bayesian analysis in clinical trials: a tutorialK Abrams, D Ashby, D Errington
European Heart Journal|January 1, 1994
Prognostic value of ambulatory ST segment monitoring compared with exercise testing at 1-3 months after acute myocardial infarctionP Currie, D Ashby, S Saltissi
Clinical Neuropharmacology|January 1, 1986
Measurement of whole blood serotonin as a guide in prescribing psychostimulant medication for children with attentional deficitsR C Saul, C D Ashby
Pageof 22

Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
The Cochrane Database of Systematic Reviews|May 5, 2000
Ursodeoxycholic acid for cystic fibrosis-related liver diseaseK Cheng, D Ashby, R Smyth
The Cochrane Database of Systematic Reviews|May 5, 2000
Oral steroids for cystic fibrosisK Cheng, D Ashby, R Smyth
Journal of the Royal Society of Medicine|January 1, 1997
Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic reviewK Cheng, D Ashby, R Smyth
The Journal of Biological Chemistry|February 25, 1973
Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzymeC D Ashby, D A Walsh
Lifetime Data Analysis|January 1, 1996
A Bayesian approach to Weibull survival models--application to a cancer clinical trialK Abrams, D Ashby, D Errington
Journal of the American Chemical Society|May 5, 2005
Ultra-sensitive imaging and interfacial analysis of patterned hydrophilic SAM surfaces using energy dissipation chemical force microscopyPaul D Ashby, Charles M Lieber
Recent Progress in Hormone Research|January 1, 1973
Protein kinases: aspects of their regulation and diversityD A Walsh, C D Ashby
Controlled Clinical Trials|October 1, 1994
Simple Bayesian analysis in clinical trials: a tutorialK Abrams, D Ashby, D Errington
European Heart Journal|January 1, 1994
Prognostic value of ambulatory ST segment monitoring compared with exercise testing at 1-3 months after acute myocardial infarctionP Currie, D Ashby, S Saltissi
Clinical Neuropharmacology|January 1, 1986
Measurement of whole blood serotonin as a guide in prescribing psychostimulant medication for children with attentional deficitsR C Saul, C D Ashby
Pageof 22